Thursday, November 28, 2024 7:54:10 AM
100%. Not even sure why they are dangling these trial carrots when they need to launch and have no resources. That costs money which they don't have. The trial dangling is to keep some kind of optimism out there while they struggle with the commercialization aka can kicking.
1 . No funds to launch
2. Haven't hired consultants to work on reimbursement
3. Have no experience in a commercial launch.
4. Have no strategy for this complicated logistical launch. Although the pumpers keep saying it sells itself LMFAO.
But keep dangling these direct and other trial carrots. Let's see how this ends up. I say 2b plus shares authorized with new carrots, excuses and narratives pushed by the paid pump crew.
No path to revenue and they keep talking about trials and adding to the spend.....it's insulting what this crew is pushing .
1 . No funds to launch
2. Haven't hired consultants to work on reimbursement
3. Have no experience in a commercial launch.
4. Have no strategy for this complicated logistical launch. Although the pumpers keep saying it sells itself LMFAO.
But keep dangling these direct and other trial carrots. Let's see how this ends up. I say 2b plus shares authorized with new carrots, excuses and narratives pushed by the paid pump crew.
No path to revenue and they keep talking about trials and adding to the spend.....it's insulting what this crew is pushing .
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
